ERBB2 and neoplasm: Furthermore, HER2-targeted CAR T-cells containing a CD3ζ signaling domain and a 4-1BB costimulatory motif (BBz) show robust anti-tumor activity against MB cell lines in vitro and in MB mouse models, where they result in rapid tumor regression [113].